Co Optical

Washington State University, $5,000

Co Optical is developing a novel, non-invasive and continuous blood glucose monitoring device to aid in management of type II diabetes. The device, structured as a pair of glasses, will non-invasively record the electrical signals present in the skin around the eyes. These signals, which correspond to the blood glucose level of the person, will be interpreted by the device.